Ahmad Al‐Saffar

445 total citations
17 papers, 344 citations indexed

About

Ahmad Al‐Saffar is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Ahmad Al‐Saffar has authored 17 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in Ahmad Al‐Saffar's work include Gastrointestinal motility and disorders (5 papers), Ion channel regulation and function (5 papers) and Receptor Mechanisms and Signaling (5 papers). Ahmad Al‐Saffar is often cited by papers focused on Gastrointestinal motility and disorders (5 papers), Ion channel regulation and function (5 papers) and Receptor Mechanisms and Signaling (5 papers). Ahmad Al‐Saffar collaborates with scholars based in Sweden, United Kingdom and United States. Ahmad Al‐Saffar's co-authors include Per M. Hellström, Elvar Theodorsson, Hans Lennernäs, Sandra A. G. Visser, Tryggve Ljung, Anna Ollerstam, Johan Gabrielsson, Göran Duker, Lars B. Nilsson and Jan M. Lundberg and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and Digestive Diseases and Sciences.

In The Last Decade

Ahmad Al‐Saffar

15 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmad Al‐Saffar Sweden 11 121 96 87 84 65 17 344
P Schiantarelli Italy 11 131 1.1× 38 0.4× 36 0.4× 101 1.2× 67 1.0× 34 381
J.A.J. Schuurkes Belgium 11 128 1.1× 35 0.4× 306 3.5× 125 1.5× 123 1.9× 14 565
J D Harry United Kingdom 11 85 0.7× 226 2.4× 27 0.3× 65 0.8× 65 1.0× 26 461
Keith S. Rotenberg United States 11 116 1.0× 17 0.2× 25 0.3× 52 0.6× 73 1.1× 20 337
Raffaella Marin Italy 12 89 0.7× 83 0.9× 38 0.4× 69 0.8× 82 1.3× 28 489
Antonio Crema Italy 12 86 0.7× 12 0.1× 133 1.5× 112 1.3× 78 1.2× 23 386
X. Y. Wei United States 7 152 1.3× 60 0.6× 85 1.0× 76 0.9× 58 0.9× 8 351
Hisanori Takanashi Japan 15 80 0.7× 24 0.3× 211 2.4× 96 1.1× 137 2.1× 38 479
Xiaojiang Zhou China 15 148 1.2× 15 0.2× 82 0.9× 36 0.4× 43 0.7× 61 632
Jeffrey D. Daubert United States 12 264 2.2× 16 0.2× 26 0.3× 316 3.8× 199 3.1× 16 504

Countries citing papers authored by Ahmad Al‐Saffar

Since Specialization
Citations

This map shows the geographic impact of Ahmad Al‐Saffar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmad Al‐Saffar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmad Al‐Saffar more than expected).

Fields of papers citing papers by Ahmad Al‐Saffar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmad Al‐Saffar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmad Al‐Saffar. The network helps show where Ahmad Al‐Saffar may publish in the future.

Co-authorship network of co-authors of Ahmad Al‐Saffar

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmad Al‐Saffar. A scholar is included among the top collaborators of Ahmad Al‐Saffar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmad Al‐Saffar. Ahmad Al‐Saffar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Al‐Saffar, Ahmad, et al.. (2019). Utility of animal gastrointestinal motility and transit models in functional gastrointestinal disorders. Best Practice & Research Clinical Gastroenterology. 40-41. 101633–101633. 10 indexed citations
2.
Al‐Saffar, Ahmad, Hans Lennernäs, & Per M. Hellström. (2019). Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited. Neurogastroenterology & Motility. 31(11). e13617–e13617. 59 indexed citations
3.
Hellström, Per M. & Ahmad Al‐Saffar. (2017). Gastroparesis: pharmacotherapy and cardiac risk. Scandinavian Journal of Gastroenterology. 53(5). 513–518. 10 indexed citations
4.
Al‐Saffar, Ahmad, et al.. (2015). Gastrointestinal Safety Pharmacology in Drug Discovery and Development. Handbook of experimental pharmacology. 229. 291–321. 16 indexed citations
5.
Quartino, Angelica, Karin Tunblad, Johanna Fälting, et al.. (2014). Prediction and Modeling of Effects on the QTc Interval for Clinical Safety Margin Assessment, Based on Single-Ascending-Dose Study Data with AZD3839. Journal of Pharmacology and Experimental Therapeutics. 350(2). 469–478. 13 indexed citations
6.
Sällström, Johan, Ahmad Al‐Saffar, & Rikard Pehrson. (2013). Pharmacokinetic–pharmacodynamic modeling of QRS-prolongation by flecainide: Heart rate-dependent effects during sinus rhythm in conscious telemetered dogs. Journal of Pharmacological and Toxicological Methods. 69(1). 24–29. 6 indexed citations
7.
Visser, Sandra A. G., et al.. (2011). Using pharmacokinetic modeling to determine the effect of drug and food on gastrointestinal transit in dogs. Journal of Pharmacological and Toxicological Methods. 64(1). 42–52. 21 indexed citations
8.
Pehrson, Rikard, et al.. (2011). Influence of emetic episodes on the assessment of cardiovascular parameters in dog telemetry studies. Journal of Pharmacological and Toxicological Methods. 64(1). e39–e39. 1 indexed citations
9.
Visser, Sandra A. G., et al.. (2008). Measurement of gastrointestinal transit using paracetamol and sulfasalazine as marker compounds in fed conscious dogs. Journal of Pharmacological and Toxicological Methods. 58(2). 147–147.
10.
Ollerstam, Anna, Sandra A. G. Visser, Göran Duker, et al.. (2007). Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs. Journal of Pharmacological and Toxicological Methods. 56(2). 131–144. 23 indexed citations
11.
Ollerstam, Anna, Sandra A. G. Visser, J. Magnus Fredriksson, et al.. (2006). A novel approach to data processing of the QT interval response in the conscious telemetered beagle dog. Journal of Pharmacological and Toxicological Methods. 55(1). 35–48. 27 indexed citations
12.
Ollerstam, Anna, Sandra A. G. Visser, Göran Eklund, et al.. (2005). Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs. Journal of Pharmacological and Toxicological Methods. 53(2). 174–183. 40 indexed citations
13.
Hellström, Per M., Ahmad Al‐Saffar, Tryggve Ljung, & Elvar Theodorsson. (1997). Endotoxin Actions on Myoelectric Activity, Transit, and Neuropeptides in the Gut (Role of Nitric Oxide). Digestive Diseases and Sciences. 42(8). 1640–1651. 45 indexed citations
14.
Lundberg, Jan M., Ahmad Al‐Saffar, Alois Saria, & Elvar Theodorsson. (1986). Reserpine-induced depletion of neuropeptide Y from cardiovascular nerves and adrenal gland due to enhanced release. Naunyn-Schmiedeberg s Archives of Pharmacology. 332(2). 163–168. 33 indexed citations
15.
Al‐Saffar, Ahmad, Elvar Theodorsson, & Sune Rosell. (1984). Nervous control of the release of neurotensin‐like immunoreactivity from the small intestine of the rat. Acta Physiologica Scandinavica. 122(1). 1–6. 19 indexed citations
16.
Rökaeus, Åke & Ahmad Al‐Saffar. (1983). The importance of bile and pancreatic juice for fat‐induced release of neurotensin‐like immunoreactivity (NTLI) from the small intestine of the rat. Acta Physiologica Scandinavica. 119(1). 33–37. 15 indexed citations
17.
Al‐Saffar, Ahmad. (1982). INFLUENCE OF THE NERVOUS SYSTEM ON THE ACTION OF NEUROTENSIN IN THE SMALL INTESTINE OF RATS. Annals of the New York Academy of Sciences. 400(1). 384–386. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026